{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T02:42:24Z","timestamp":1777603344270,"version":"3.51.4"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,12]],"date-time":"2022-08-12T00:00:00Z","timestamp":1660262400000},"content-version":"am","delay-in-days":284,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["P30EY001792"],"award-info":[{"award-number":["P30EY001792"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["P30EY002687"],"award-info":[{"award-number":["P30EY002687"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["R21EY030524"],"award-info":[{"award-number":["R21EY030524"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["R34EY023633"],"award-info":[{"award-number":["R34EY023633"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","award":["P30EY001792"],"award-info":[{"award-number":["P30EY001792"]}],"id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","award":["P30EY002687"],"award-info":[{"award-number":["P30EY002687"]}],"id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","award":["R21EY030524"],"award-info":[{"award-number":["R21EY030524"]}],"id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","award":["R34EY023633"],"award-info":[{"award-number":["R34EY023633"]}],"id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30EY001792"],"award-info":[{"award-number":["P30EY001792"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30EY002687"],"award-info":[{"award-number":["P30EY002687"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R21EY030524"],"award-info":[{"award-number":["R21EY030524"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R34EY023633"],"award-info":[{"award-number":["R34EY023633"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajo.com","clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.ajo.2021.05.018","type":"journal-article","created":{"date-parts":[[2021,6,6]],"date-time":"2021-06-06T05:23:44Z","timestamp":1622957024000},"page":"28-38","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Efficacy of a Single Administration of 5% Povidone-Iodine in the Treatment of Adenoviral Conjunctivitis"],"prefix":"10.1016","volume":"231","author":[{"given":"Tammy","family":"Than","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina E.","family":"Morettin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer S.","family":"Harthan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew T.E.","family":"Hartwick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia B.","family":"Huecker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Spencer D.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary K.","family":"Migneco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ellen","family":"Shorter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meredith","family":"Whiteside","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian K.","family":"Olson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher S.","family":"Alferez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tav\u00e9","family":"van Zyl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bojana","family":"Rodic-Polic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory A.","family":"Storch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mae O.","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.ajo.2021.05.018_bib0001","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/s40135-019-00207-y","article-title":"Adenoviral keratoconjunctivitis: Diagnosis, management, and prevention","author":"Kuo","year":"2019","journal-title":"Curr Ophthalmol Rep"},{"issue":"12","key":"10.1016\/j.ajo.2021.05.018_bib0002","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1016\/S0161-6420(93)31389-8","article-title":"Prolonged recovery of desiccated adenoviral serotypes 5, 8, and 19 from plastic and metal surfaces in vitro","volume":"100","author":"Gordon","year":"1993","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.ajo.2021.05.018_bib0003","first-page":"63","article-title":"Keratoconjunctivitis due to adenovirus type 8: Report on a large outbreak","volume":"23","author":"Colon","year":"1991","journal-title":"Ann Ophthalmol"},{"issue":"5","key":"10.1016\/j.ajo.2021.05.018_bib0004","first-page":"826","article-title":"Simultaneous nosocomial and community outbreak of epidemic keratoconjunctivitis with types 8 and 19 adenovirus","volume":"81","author":"Vastine","year":"1976","journal-title":"Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol"},{"issue":"121","key":"10.1016\/j.ajo.2021.05.018_bib0005","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1001\/jama.1943.02840040026007","article-title":"FD. Epidemic keratoconjunctivitis. Clinical and experimental study of an outbreak in New York City: Further observations on the specific relationship between a virus and the disease","author":"Sanders","year":"1943","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.ajo.2021.05.018_bib0006","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1097\/00043764-198909000-00014","article-title":"An outbreak of infectious conjunctivitis spread by microscopes","volume":"31","author":"Doyle","year":"1989","journal-title":"J Occup Med"},{"issue":"3","key":"10.1016\/j.ajo.2021.05.018_bib0007","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1017\/S0022172400066365","article-title":"Adenovirus type 8 keratoconjunctivitis\u2013An outbreak and its treatment with topical human fibroblast interferon","volume":"96","author":"Reilly","year":"1986","journal-title":"J Hyg (Lond)"},{"issue":"2","key":"10.1016\/j.ajo.2021.05.018_bib0008","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1017\/S0950268899004550","article-title":"The epidemiology of adenovirus infections in Greater Manchester, UK 1982-96","volume":"125","author":"Cooper","year":"2000","journal-title":"Epidemiol Infect"},{"issue":"3","key":"10.1016\/j.ajo.2021.05.018_bib0009","first-page":"326","article-title":"Adenovirus type 19 keratoconjunctivitis in Canada","volume":"10","author":"Jackson","year":"1975","journal-title":"Can J Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2021.05.018_bib0010","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1001\/archopht.1968.00980050469011","article-title":"Community and hospital outbreak of epidemic keratoconjunctivitis","volume":"80","author":"Laibson","year":"1968","journal-title":"Arch Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2021.05.018_bib0011","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1442-9071.1981.tb00911.x","article-title":"Adeno-viral kerato conjunctivitis","volume":"9","author":"Stasiuk","year":"1981","journal-title":"Aust J Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2021.05.018_bib0012","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.jpeds.2004.11.032","article-title":"Outbreak of adenovirus type 30 in a neonatal intensive care unit","volume":"146","author":"Faden","year":"2005","journal-title":"J Pediatr"},{"issue":"9","key":"10.1016\/j.ajo.2021.05.018_bib0013","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1017\/S0950268807009843","article-title":"An outbreak of epidemic keratoconjunctivitis in a regional ophthalmology clinic in New South Wales","volume":"136","author":"Viney","year":"2008","journal-title":"Epidemiol Infect"},{"issue":"6","key":"10.1016\/j.ajo.2021.05.018_bib0014","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1093\/infdis\/160.6.938","article-title":"A large outbreak of epidemic keratoconjunctivitis: Problems in controlling nosocomial spread","volume":"160","author":"Warren","year":"1989","journal-title":"J Infect Dis"},{"issue":"27","key":"10.1016\/j.ajo.2021.05.018_bib0015","first-page":"475","article-title":"Epidemic keratoconjunctivitis: The current situation and recommendations for prevention and treatment","volume":"108","author":"Meyer-Rusenberg","year":"2011","journal-title":"Dtsch Arztebl Int"},{"issue":"1","key":"10.1016\/j.ajo.2021.05.018_bib0016","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/00004397-200201000-00008","article-title":"A twenty-one year surveillance of adenoviral conjunctivitis in Sapporo, Japan","volume":"42","author":"Aoki","year":"2002","journal-title":"Int Ophthalmol Clin"},{"issue":"3","key":"10.1016\/j.ajo.2021.05.018_bib0017","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1097\/MAJ.0b013e3181637417","article-title":"Cost effectiveness of a point-of-care test for adenoviral conjunctivitis","volume":"336","author":"Udeh","year":"2008","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.ajo.2021.05.018_bib0018","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ajo.2015.12.007","article-title":"A polymerase chain reaction-based algorithm to detect and prevent transmission of adenoviral conjunctivitis in hospital employees","volume":"163","author":"Kuo","year":"2016","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2021.05.018_bib0019","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1089\/jop.2011.0082","article-title":"Treatment of epidemic keratoconjunctivitis with 2% povidone-iodine: A pilot study","volume":"28","author":"Trinavarat","year":"2012","journal-title":"J Ocul Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.ajo.2021.05.018_bib0020","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1089\/jop.2018.0122","article-title":"The in vitro evaluation of povidone-iodine against multiple ocular adenoviral types","volume":"35","author":"Yates","year":"2019","journal-title":"J Ocul Pharmacol Ther"},{"issue":"Suppl 2","key":"10.1016\/j.ajo.2021.05.018_bib0021","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1159\/000246027","article-title":"Inactivation of human viruses by povidone-iodine in comparison with other antiseptics","volume":"195","author":"Kawana","year":"1997","journal-title":"Dermatology"},{"key":"10.1016\/j.ajo.2021.05.018_bib0022","article-title":"Adenoviral conjunctivitis. How to use povidone-iodine for treatment.","author":"Abel","year":"2000","journal-title":"Ophthalmology Management"},{"key":"10.1016\/j.ajo.2021.05.018_bib0023","unstructured":"Abelson M, Shapiro A. A guide to understanding adenovirus, the diseases it causes and the best ways to treat these conditions. Review of Ophthalmology Web site. Published 2010. Available at https:\/\/www.reviewofophthalmology.com\/article\/a-guide-to-understanding-adenovirus-the-diseases-it-causes-and-the-best-ways-to-treat-these-conditions. Accessed June 28, 2021"},{"key":"10.1016\/j.ajo.2021.05.018_bib0024","unstructured":"Shovlin JP. What's the Buzz About Betadine? Review of Ophthalmology Web site. Published 2011. Available at https:\/\/www.reviewofoptometry.com\/article\/whats-the-buzz-about-betadine. Accessed June 28, 2021."},{"issue":"5","key":"10.1016\/j.ajo.2021.05.018_bib0025","first-page":"323","article-title":"[Personal experience with the use of Betadine gtt. in the treatment of epidemic viral keratoconjunctivitis]","volume":"50","author":"Pernicky","year":"1994","journal-title":"Cesk Oftalmol"},{"key":"10.1016\/j.ajo.2021.05.018_bib0026","unstructured":"Than T, Hartwick A, Shorter E, et\u00a0al. How to manage adenoviral conjunctivitis. Optometry Times Web site. Available at http:\/\/optometrytimes.modernmedicine.com\/optometrytimes\/news\/how-manage-adenoviral-conjunctivitis. Published 2014. Accessed June 28, 2021."},{"key":"10.1016\/j.ajo.2021.05.018_bib0027","doi-asserted-by":"crossref","first-page":"535","DOI":"10.2147\/OPTH.S191275","article-title":"A randomized controlled trial of povidone-iodine\/dexamethasone ophthalmic suspension for acute viral conjunctivitis","volume":"13","author":"Pepose","year":"2019","journal-title":"Clin Ophthalmol"},{"issue":"8","key":"10.1016\/j.ajo.2021.05.018_bib0028","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1007\/s12325-009-0062-1","article-title":"A combination povidone-iodine 0.4%\/dexamethasone 0.1% ophthalmic suspension in the treatment of adenoviral conjunctivitis","volume":"26","author":"Pelletier","year":"2009","journal-title":"Adv Ther"},{"issue":"9","key":"10.1016\/j.ajo.2021.05.018_bib0029","doi-asserted-by":"crossref","first-page":"870","DOI":"10.3109\/02713683.2014.964419","article-title":"Dexamethasone\/povidone eye drops versus artificial tears for treatment of presumed viral conjunctivitis: A randomized clinical trial","volume":"40","author":"Pinto","year":"2015","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.ajo.2021.05.018_bib0030","doi-asserted-by":"crossref","first-page":"e686","DOI":"10.1111\/aos.13416","article-title":"Treatment of adenoviral keratoconjunctivitis with a combination of povidone-iodine 1.0% and dexamethasone 0.1% drops: A clinical prospective controlled randomized study","volume":"Dec;95(8)","author":"Kovalyuk","year":"2017","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.ajo.2021.05.018_bib0031","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ajo.2018.05.012","article-title":"Randomized, controlled, phase 2 trial of povidone-iodine\/dexamethasone ophthalmic suspension for treatment of adenoviral conjunctivitis","volume":"194","author":"Pepose","year":"2018","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2021.05.018_bib0032","unstructured":"QuickVue Adenoviral Conjunctivitis Test: Manufacturer's Instructions. Quidel Corporation Web site. Available at http:\/\/www.quidel.com\/sites\/default\/files\/product\/documents\/EF1361400EN00.pdf. Accessed June 28, 2021."},{"issue":"3","key":"10.1016\/j.ajo.2021.05.018_bib0033","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1097\/00006324-199303000-00011","article-title":"CCLRU standards for success of daily and extended wear contact lenses","volume":"70","author":"Terry","year":"1993","journal-title":"Optom Vis Sci"},{"issue":"4","key":"10.1016\/j.ajo.2021.05.018_bib0034","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.jtos.2019.08.005","article-title":"Safety and tolerability of a one-time, in-office administration of 5% povidone-iodine in the treatment of adenoviral conjunctivitis: The Reducing Adenoviral Patient Infected Days (RAPID) study","volume":"17","author":"Shorter","year":"2019","journal-title":"Ocul Surf"},{"issue":"9","key":"10.1016\/j.ajo.2021.05.018_bib0035","article-title":"Reducing Adenoviral Patient Infected Days (RAPID) study: Success in masking subjects and clinicians from identifying treatment with ophthalmic povidone-iodine 5% (PVP-I)","volume":"59","author":"Whiteside","year":"2018","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"9","key":"10.1016\/j.ajo.2021.05.018_bib0036","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/j.ophtha.2018.02.016","article-title":"Determinants of outcomes of adenoviral keratoconjunctivitis","volume":"125","author":"Lee","year":"2018","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.ajo.2021.05.018_bib0037","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/01.ico.0000170693.13326.fb","article-title":"Adenoviral keratoconjunctivitis in a tertiary care eye clinic","volume":"25","author":"Butt","year":"2006","journal-title":"Cornea"},{"key":"10.1016\/j.ajo.2021.05.018_bib0038","series-title":"Ocular Pathology","author":"Yanoff","year":"2020"},{"issue":"10","key":"10.1016\/j.ajo.2021.05.018_bib0039","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.2337\/diacare.20.10.1512","article-title":"Impact of dosage frequency on patient compliance","volume":"20","author":"Paes","year":"1997","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.ajo.2021.05.018_bib0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jtos.2019.10.007","article-title":"Clinical metagenomics for infectious corneal ulcers: Rags to riches?","volume":"18","author":"Ung","year":"2020","journal-title":"Ocul Surf"},{"issue":"1","key":"10.1016\/j.ajo.2021.05.018_bib0041","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1001\/2013.jamaophthalmol.513","article-title":"Sensitivity and specificity of the AdenoPlus test for diagnosing adenoviral conjunctivitis","volume":"131","author":"Sambursky","year":"2013","journal-title":"JAMA Ophthalmol"},{"issue":"8","key":"10.1016\/j.ajo.2021.05.018_bib0042","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1185\/03007990903038269","article-title":"Acute conjunctivitis: Truth and misconceptions","volume":"25","author":"O'Brien","year":"2009","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.ajo.2021.05.018_bib0043","article-title":"Diagnostic misclassification: Possible explanation for unsuccessful therapeutic trials of \u201cpink eye","author":"Gordon","year":"2015","journal-title":"Presented at: Society for Clinical Trials"},{"key":"10.1016\/j.ajo.2021.05.018_bib0044","series-title":"The evaluation of worldwide distribution of adenoviral genotypes in acute\/epidemic keratoconjunctivitis and adenoviral-negative keratoconjunctivitis with next generation sequencing","author":"Lee","year":"2016"},{"issue":"9","key":"10.1016\/j.ajo.2021.05.018_bib0045","first-page":"6257","article-title":"Reducing Adenoviral Patient-Infected Days (RAPID) Study: A randomized trial assessing efficacy of one time, in-office application of 5% povidone-iodine in treatment of adenoviral conjunctivitis","volume":"60","author":"Hartwick","year":"2019","journal-title":"Investigative Ophthalmology & Visual Science"},{"issue":"6","key":"10.1016\/j.ajo.2021.05.018_bib0046","first-page":"341","article-title":"Use of povidone-iodine in the treatment of presumptive adenoviral conjunctivitis","volume":"30","author":"Abel","year":"1998","journal-title":"Ann Ophthalmol & Glaucoma"}],"updated-by":[{"DOI":"10.1016\/j.ajo.2021.12.001","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000}}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939421003111?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939421003111?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T20:54:50Z","timestamp":1671656090000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939421003111"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":46,"alternative-id":["S0002939421003111"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2021.05.018","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.ajo.2021.12.001","asserted-by":"object"}]},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of a Single Administration of 5% Povidone-Iodine in the Treatment of Adenoviral Conjunctivitis","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2021.05.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}